They concluded that this therapy effectively delayed the retinal degeneration, enhanced the retinal cell survival, and improved the visual function, and that this was mainly due to ADMSC-dependent anti-apoptotic and neuroprotective effects through its secretion of growth and neurotrophic factors including VEGF [32]. The gene discussed is VEGFA; the disease is retinal degeneration.